Clinical Trial Update: SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal Dysfunction [Phase 3]

View source ↗

Summary

This entry reports the completion of a Phase 3 clinical trial evaluating SPP100 (aliskiren) regimens in hypertensive patients with renal dysfunction, sponsored …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• SPP100 (Aliskiren) (Aliskiren)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED